In situ tumor vaccination with adenovirus vectors encoding measles virus fusogenic membrane proteins and cytokines

doi:10.3748/wjg.v13.i22.3063

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 22

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3173)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series.

Item

Count

PDF

483

HTML

2445

Figures (1-5)

245

Sum=3173

Jun 14, 2007 (publication date) through Nov 9, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Jun 14, 2007; 13(22): 3063-3070
Published online Jun 14, 2007. doi: 10.3748/wjg.v13.i22.3063

Full Size Figure Download Figure

Figure 4 T cell mediated tumor regression by expression of MV-FMG alone or in combination with cytokines. Data of all animals were expressed as the percentage of specific release of three independent experiments (mean ± SD).

Citation: Hoffmann D, Bayer W, Wildner O. In situ tumor vaccination with adenovirus vectors encoding measles virus fusogenic membrane proteins and cytokines. World J Gastroenterol 2007; 13(22): 3063-3070
URL: https://www.wjgnet.com/1007-9327/full/v13/i22/3063.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i22.3063